Because appetite, weight and blood sugar levels may change when GLP-1s are paused or resumed, working closely with your health care team can help you navigate these transitions safely and most effectively
After four weeks, you will have clear data showing which sites work best for your body
A 2025 analysis of FDA adverse event reports indicated that the odds of reporting vision impairment with these drugs were nearly twice as high as for other medications
Combined with clinical monitoring, this context supports more personalized treatment decisions
Semaglutide Use Prior to Total Hip Arthroplasty Results in Fewer Postoperative Prosthetic Joint Infections and Readmissions
Finally, we hypothesize that Cav-1 may regulate GLP-1 action binding both GLP-1R and -arrestin-1, and modulating the activity of Dipeptidyl Peptidase (DPP)-IV